{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:06:19Z","timestamp":1769551579129,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2882,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.seizure.2005.08.002","type":"journal-article","created":{"date-parts":[[2005,9,23]],"date-time":"2005-09-23T09:51:32Z","timestamp":1127469092000},"page":"476-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany"],"prefix":"10.1016","volume":"14","author":[{"given":"Joachim","family":"Opp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Tuxhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodor","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelheid","family":"Wiemer-Kruel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Kurlemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunther","family":"Gross-Selbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietz","family":"Rating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Bettendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"H\u00e4rtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Korn-Merker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.seizure.2005.08.002_bib1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of Levetiracetam 3000mg\/day in patients with refractory partial seizures: a multicenter double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2005.08.002_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2005.08.002_bib3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of Levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.002_bib4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1528-1157.2001.41300.x","article-title":"Pharmacokinetic study of Levetiracetam in children","volume":"42","author":"Pellock","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.002_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1059-1311(03)00111-0","article-title":"Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam","volume":"13","author":"Mula","year":"2004","journal-title":"Seizure"},{"issue":"Suppl. 8","key":"10.1016\/j.seizure.2005.08.002_bib6","first-page":"184","article-title":"Treatment with levetiracetam in childhood epilepsies according to classification","volume":"43","author":"Weyrheter","year":"2003","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.seizure.2005.08.002_bib7","first-page":"9","article-title":"Behavioural profile of levetiracetam in children","volume":"43","author":"Kugler","year":"2002","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.seizure.2005.08.002_bib8","first-page":"58","article-title":"Behavioural and emotional effects of Levetiracetam in children with epilepsy","volume":"43","author":"Gustafson","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.002_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.seizure.2003.09.010","article-title":"Enterocolitis: an adverse event in refractory epilepsy patients treated with levetiracetam?","volume":"13","author":"Bosman","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2005.08.002_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eplepsyres.2004.03.006","article-title":"Levetiracetam during 1-year follow up in children, adolescents, and young adults with refractory epilepsy","volume":"59","author":"Coppola","year":"2004","journal-title":"Epilepsy Res"},{"issue":"Suppl. 7","key":"10.1016\/j.seizure.2005.08.002_bib11","first-page":"53","article-title":"Open label assessment of levetiracetam efficacy and adverse events in a pediatric population","volume":"42","author":"Bourgeois","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.002_bib12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1090-3798(03)00041-2","article-title":"Effect of levetiracetam in refractory childhood epilepsy syndromes","volume":"7","author":"Lagae","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"issue":"Suppl. 3","key":"10.1016\/j.seizure.2005.08.002_bib13","first-page":"143","article-title":"Efficacy of levetiracetam in children with partial seizures","volume":"45","author":"Nieto Barrera","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.seizure.2005.08.002_bib14","first-page":"37","article-title":"Levetiracetam therapy in children and adolescents with intractable epilepsy","volume":"43","author":"Veendrick-Meekes","year":"2002","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.seizure.2005.08.002_bib15","first-page":"144","article-title":"Efficacy of levetiracetam as add-on therapy for 51 children with refractory epilepsy","volume":"45","author":"Garcia-Pe\u0148as","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.002_bib16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1528-1157.2002.13101.x","article-title":"Efficacy and safety of levetiracetam in children with partial seizures: an open label trial","volume":"43","author":"Glauser","year":"2002","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.seizure.2005.08.002_bib17","first-page":"144","article-title":"Adjunctive levetiracetam in 133 children with pharmacoresistant epileptic seizures","volume":"45","author":"Herranz","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.seizure.2005.08.002_bib18","first-page":"143","article-title":"Levetiracetam in children with intractable epilepsy: Preliminary results of a clinical audit","volume":"45","author":"Mordekar","year":"2004","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.seizure.2005.08.002_bib19","first-page":"144","article-title":"Levetiracetam in childhood treatment-resistant epilepsy","volume":"45","author":"Papavasiliou","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.08.002_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1059-1311(03)00193-6","article-title":"Efficacy and tolerability of levetiracetam in children aged ten years and younger: a clinical experience","volume":"13","author":"Tan","year":"2004","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2005.08.002_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1059131102001723","article-title":"A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy","volume":"12","author":"Nakken","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2005.08.002_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/088307380201700603","article-title":"Levetiracetam in refractory pediatric epilepsy","volume":"17","author":"Wannag","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2005.08.002_bib23","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.56.12.1772","article-title":"Long-term continuation of levetiracetam in patients with refractory epilepsy","volume":"56","author":"Krakow","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2005.08.002_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/088307380201700603","article-title":"Levetiracetam in refractory pediatric epilepsy","volume":"17","author":"Wheless","year":"2002","journal-title":"J Child Neurol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131105001457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131105001457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:33:31Z","timestamp":1761010411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131105001457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S1059131105001457"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2005.08.002","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam in children with refractory epilepsy: A multicenter open label study in Germany","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2005.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}